LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer.

Zhang, Qiang / Jiang, Long / Wang, Weiwei / Huber, Amanda K / Valvo, Victoria M / Jungles, Kassidy M / Holcomb, Erin A / Pearson, Ashley N / The, Stephanie / Wang, Zhuwen / Parsels, Leslie A / Parsels, Joshua D / Wahl, Daniel R / Rao, Arvind / Sahai, Vaibhav / Lawrence, Theodore S / Green, Michael D / Morgan, Meredith A

JCI insight

2024  Volume 9, Issue 6

Abstract: Radiotherapy induces a type I interferon-mediated (T1IFN-mediated) antitumoral immune response that we hypothesized could be potentiated by a first-in-class ataxia telangiectasia mutated (ATM) inhibitor, leading to enhanced innate immune signaling, T1IFN ...

Abstract Radiotherapy induces a type I interferon-mediated (T1IFN-mediated) antitumoral immune response that we hypothesized could be potentiated by a first-in-class ataxia telangiectasia mutated (ATM) inhibitor, leading to enhanced innate immune signaling, T1IFN expression, and sensitization to immunotherapy in pancreatic cancer. We evaluated the effects of AZD1390 or a structurally related compound, AZD0156, on innate immune signaling and found that both inhibitors enhanced radiation-induced T1IFN expression via the POLIII/RIG-I/MAVS pathway. In immunocompetent syngeneic mouse models of pancreatic cancer, ATM inhibitor enhanced radiation-induced antitumoral immune responses and sensitized tumors to anti-PD-L1, producing immunogenic memory and durable tumor control. Therapeutic responses were associated with increased intratumoral CD8+ T cell frequency and effector function. Tumor control was dependent on CD8+ T cells, as therapeutic efficacy was blunted in CD8+ T cell-depleted mice. Adaptive immune responses to combination therapy provided systemic control of contralateral tumors outside of the radiation field. Taken together, we show that a clinical candidate ATM inhibitor enhances radiation-induced T1IFN, leading to both innate and subsequent adaptive antitumoral immune responses and sensitization of otherwise resistant pancreatic cancer to immunotherapy.
MeSH term(s) Animals ; Mice ; Interferon Type I ; Ataxia Telangiectasia ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/radiotherapy ; Pancreatic Neoplasms/pathology ; Immunity ; Pyridines ; Quinolones
Chemical Substances Interferon Type I ; AZD1390 ; Pyridines ; Quinolones
Language English
Publishing date 2024-02-20
Publishing country United States
Document type Journal Article
ISSN 2379-3708
ISSN (online) 2379-3708
DOI 10.1172/jci.insight.168824
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top